Table CS1: Consistent series of drug-related deaths - 'extra' deaths and which of the drugs that were present for each of the 'extra' deaths meant that they were counted in the consistent series: 2000 to 2015
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
Footnote:
Broadly speaking, counting deaths on the basis of the classification of the drugs at the end of the latest year which is covered by the publication. refer to Annex F for the full definition.
Broadly speaking, counting deaths on the basis of the classification of the drugs at the time of death. refer to Annex A for the full definition.
For example, deaths which are counted in the consistent series but are not counted in the standard definition.
Mephedrone has been a controlled substance with effect from 16 April 2010, so subsequent deaths involving it are counted in the 'standard definition' figures (and not 'extra' deaths).
Phenazepam has been a controlled substance with effect from 13 June 2012, so subsequent deaths involving it are counted in the 'standard definition' figures (and not 'extra' deaths).
Tramadol and zopiclone have been controlled substances with effect from 10 June 2014, so subsequent deaths involving either (or both) of them are counted in the 'standard definition' figures (and not 'extra' deaths).
For example, one or more of APB, API and BZP were present.
Drug-related deaths: consistent series1
293
339
388
330
365
346
430
474
590
570
512
606
604
557
618
706
Drug-related deaths: standard definition2
292
332
382
317
356
336
421
455
574
545
485
584
581
527
613
706
'Extra' deaths counted in the consistent series3
1
7
6
13
9
10
9
19
16
25
27
22
23
30
5
0
of which:
Mephedrone4 present
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
Phenazepam5 present
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
Tramadol6 present
0
5
2
12
8
9
9
16
14
19
17
12
17
27
3
0
Zopiclone6 present
1
2
4
1
1
1
0
4
2
6
7
9
7
1
0
0
None of the above but one or more other substances which are now controlled were present7